Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIMH

Peptides which inhibit aids virus infectivity

  • Read more about Peptides which inhibit aids virus infectivity
US Application 06/869,919
Filed on 1986-06-03

SILVER STAIN FOR RAPID, QUANTITATIVE DETECTION OF POLYPEPTIDES AND NUCLEIC ACIDS

  • Read more about SILVER STAIN FOR RAPID, QUANTITATIVE DETECTION OF POLYPEPTIDES AND NUCLEIC ACIDS
US Patent 4,703,016
Filed on 1986-05-05

Human-mouse hybrid cell line expressing monocyte-macrophage properties

  • Read more about Human-mouse hybrid cell line expressing monocyte-macrophage properties
US Patent 4,970,162
Filed on 1985-11-13

RAPID VISUALIZATION SYSTEM FOR GEL ELECTROPHORESIS

  • Read more about RAPID VISUALIZATION SYSTEM FOR GEL ELECTROPHORESIS
US Patent 4,555,490
Filed on 1984-06-08

TREATMENT OF GRAFT VERSUS HOST DISEASE USING A MIXTURE OF T-LYMPHOCYTE SPECIFIC MONOCLONAL ANTIBODY: RICIN CONJUGATE

  • Read more about TREATMENT OF GRAFT VERSUS HOST DISEASE USING A MIXTURE OF T-LYMPHOCYTE SPECIFIC MONOCLONAL ANTIBODY: RICIN CONJUGATE
US Patent 4,520,226
Filed on 1983-01-07

PREVENTION OF GRAFT VERSUS HOST DISEASE FOLLOWING BONE MARROW TRANSPLANTATION

  • Read more about PREVENTION OF GRAFT VERSUS HOST DISEASE FOLLOWING BONE MARROW TRANSPLANTATION
US Patent 4,500,637
Filed on 1982-07-19

MONOCLONAL ANTIBODY-RICIN HYBRIDS AS A TREATMENT OF MURINE GRAFT-VERSUS-HOST DISEASE.

  • Read more about MONOCLONAL ANTIBODY-RICIN HYBRIDS AS A TREATMENT OF MURINE GRAFT-VERSUS-HOST DISEASE.
US Patent 4,440,747
Filed on 1982-02-19

INACTIVATING PROTEIN SYNTHESIS BY INCUBATING ANTI-THY 1.1-RICIN A CHAIN MONOCLONAL ANTIBODY HYBRIDS W/ TARGET

  • Read more about INACTIVATING PROTEIN SYNTHESIS BY INCUBATING ANTI-THY 1.1-RICIN A CHAIN MONOCLONAL ANTIBODY HYBRIDS W/ TARGET
US Patent 4,520,011
Filed on 1982-02-19

MANNOSE-6-PHOSPHATE-LOW DENSITY PROTEIN REAGENT EFFECTIVE AGAINST HYPERCHOLESTEROLEMIA.

  • Read more about MANNOSE-6-PHOSPHATE-LOW DENSITY PROTEIN REAGENT EFFECTIVE AGAINST HYPERCHOLESTEROLEMIA.
US Patent 4,397,843
Filed on 1982-01-21

(+/-)3-Deazaaristeromycin and uses

  • Read more about (+/-)3-Deazaaristeromycin and uses
US Patent 4,386,093
Filed on 1981-09-16

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 78
  • Page 79
  • Page 80
  • Page 81
  • Page 82
  • Page 83
  • Page 84
  • Page 85
  • Page 86
  • Next page ››
  • Last page Last »
Subscribe to NIMH
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health